23andMe Reports Q1 Revenue Drop, Narrows Losses
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
- Latest
- Trending
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Hawaiian Electric struggles with financing $1.99 billion Maui wildfire settlement amid going concern doubts.
Exploring the implications of rising U.S. government debt on investor interest rates and inflation concerns.
Primo Water sees 7.6% revenue rise in Q2 2024, prepares for BlueTriton merger to expand product offerings.
Arbe Robotics secures contracts with major OEMs, anticipates revenue growth by 2025, despite current financial challenges.
Stifel revises Celsius Holdings' price target to $61, citing future sales adjustments and increased spending. Buy rating maintained.
Panda Biotech enters a 12-year PILOT agreement with Wichita Falls, paying reduced city taxes and utilizing city services.
Thai banks finance Myanmar junta's war, UN expert reports. Financial support prolongs conflict and human rights abuses. International call to ...
"Howard Hughes Holdings Exec Elena Verbinskaya shows confidence in company by purchasing $22,390 in stock amid key developments and financial ...
22nd Century Group cuts debt by $1.5M, aiming for financial stability and progress in tobacco harm reduction using advanced technology.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.